158 related articles for article (PubMed ID: 25479771)
1. Identification of potent inhibitors of the chicken soluble epoxide hydrolase.
Shihadih DS; Harris TR; Yang J; Merzlikin O; Lee KS; Hammock BD; Morisseau C
Bioorg Med Chem Lett; 2015 Jan; 25(2):276-9. PubMed ID: 25479771
[TBL] [Abstract][Full Text] [Related]
2. Potent urea and carbamate inhibitors of soluble epoxide hydrolases.
Morisseau C; Goodrow MH; Dowdy D; Zheng J; Greene JF; Sanborn JR; Hammock BD
Proc Natl Acad Sci U S A; 1999 Aug; 96(16):8849-54. PubMed ID: 10430859
[TBL] [Abstract][Full Text] [Related]
3. Exploring the size of the lipophilic unit of the soluble epoxide hydrolase inhibitors.
Codony S; Valverde E; Leiva R; Brea J; Isabel Loza M; Morisseau C; Hammock BD; Vázquez S
Bioorg Med Chem; 2019 Oct; 27(20):115078. PubMed ID: 31488357
[TBL] [Abstract][Full Text] [Related]
4. Pharmacophoric modeling and atom-based 3D-QSAR of novel 1-aryl-3-(1-acylpiperidin-4-yl) urea as human soluble epoxide hydrolase inhibitors (sEHIs).
Das N; Dhanawat M; Kulshrestha A; Shrivastava SK
Med Chem; 2011 Nov; 7(6):581-92. PubMed ID: 22313298
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic screening of soluble epoxide hydrolase inhibitors in dogs.
Tsai HJ; Hwang SH; Morisseau C; Yang J; Jones PD; Kasagami T; Kim IH; Hammock BD
Eur J Pharm Sci; 2010 Jun; 40(3):222-38. PubMed ID: 20359531
[TBL] [Abstract][Full Text] [Related]
6. Symmetric adamantyl-diureas as soluble epoxide hydrolase inhibitors.
Burmistrov V; Morisseau C; Lee KS; Shihadih DS; Harris TR; Butov GM; Hammock BD
Bioorg Med Chem Lett; 2014 May; 24(9):2193-7. PubMed ID: 24685540
[TBL] [Abstract][Full Text] [Related]
7. Exploration of secondary and tertiary pharmacophores in unsymmetrical N,N'-diaryl urea inhibitors of soluble epoxide hydrolase.
Anandan SK; Gless RD
Bioorg Med Chem Lett; 2010 May; 20(9):2740-4. PubMed ID: 20363133
[TBL] [Abstract][Full Text] [Related]
8. 1,3-Disubstituted and 1,3,3-trisubstituted adamantyl-ureas with isoxazole as soluble epoxide hydrolase inhibitors.
Burmistrov V; Morisseau C; Danilov D; Harris TR; Dalinger I; Vatsadze I; Shkineva T; Butov GM; Hammock BD
Bioorg Med Chem Lett; 2015 Dec; 25(23):5514-9. PubMed ID: 26520661
[TBL] [Abstract][Full Text] [Related]
9. Biologically active ester derivatives as potent inhibitors of the soluble epoxide hydrolase.
Kim IH; Nishi K; Kasagami T; Morisseau C; Liu JY; Tsai HJ; Hammock BD
Bioorg Med Chem Lett; 2012 Sep; 22(18):5889-92. PubMed ID: 22901393
[TBL] [Abstract][Full Text] [Related]
10. Optimization of piperidyl-ureas as inhibitors of soluble epoxide hydrolase.
Eldrup AB; Soleymanzadeh F; Farrow NA; Kukulka A; De Lombaert S
Bioorg Med Chem Lett; 2010 Jan; 20(2):571-5. PubMed ID: 19969453
[TBL] [Abstract][Full Text] [Related]
11. Relative Importance of Soluble and Microsomal Epoxide Hydrolases for the Hydrolysis of Epoxy-Fatty Acids in Human Tissues.
Morisseau C; Kodani SD; Kamita SG; Yang J; Lee KSS; Hammock BD
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34066758
[TBL] [Abstract][Full Text] [Related]
12. Preparation and evaluation of soluble epoxide hydrolase inhibitors with improved physical properties and potencies for treating diabetic neuropathic pain.
Lee KSS; Ng JC; Yang J; Hwang SH; Morisseau C; Wagner K; Hammock BD
Bioorg Med Chem; 2020 Nov; 28(22):115735. PubMed ID: 33007552
[TBL] [Abstract][Full Text] [Related]
13. Discovery of Potent Soluble Epoxide Hydrolase (sEH) Inhibitors by Pharmacophore-Based Virtual Screening.
Waltenberger B; Garscha U; Temml V; Liers J; Werz O; Schuster D; Stuppner H
J Chem Inf Model; 2016 Apr; 56(4):747-62. PubMed ID: 26882208
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and structure-activity relationship of piperidine-derived non-urea soluble epoxide hydrolase inhibitors.
Pecic S; Pakhomova S; Newcomer ME; Morisseau C; Hammock BD; Zhu Z; Rinderspacher A; Deng SX
Bioorg Med Chem Lett; 2013 Jan; 23(2):417-21. PubMed ID: 23237835
[TBL] [Abstract][Full Text] [Related]
15. Development of potent inhibitors of the human microsomal epoxide hydrolase.
Barnych B; Singh N; Negrel S; Zhang Y; Magis D; Roux C; Hua X; Ding Z; Morisseau C; Tantillo DJ; Siegel JB; Hammock BD
Eur J Med Chem; 2020 May; 193():112206. PubMed ID: 32203787
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of soluble epoxide hydrolase by fulvestrant and sulfoxides.
Morisseau C; Pakhomova S; Hwang SH; Newcomer ME; Hammock BD
Bioorg Med Chem Lett; 2013 Jul; 23(13):3818-21. PubMed ID: 23684894
[TBL] [Abstract][Full Text] [Related]
17. Structural refinement of inhibitors of urea-based soluble epoxide hydrolases.
Morisseau C; Goodrow MH; Newman JW; Wheelock CE; Dowdy DL; Hammock BD
Biochem Pharmacol; 2002 May; 63(9):1599-608. PubMed ID: 12007563
[TBL] [Abstract][Full Text] [Related]
18. Novel amide derivatives of 3-phenylglutaric acid as potent soluble epoxide hydrolase inhibitors.
Rezaee E; Amrolah SM; Nazari M; Tabatabai SA
Mol Divers; 2021 Feb; 25(1):45-53. PubMed ID: 31873869
[TBL] [Abstract][Full Text] [Related]
19. The 5-substituted piperazine as a novel secondary pharmacophore greatly improving the physical properties of urea-based inhibitors of soluble epoxide hydrolase.
Li HY; Jin Y; Morisseau C; Hammock BD; Long YQ
Bioorg Med Chem; 2006 Oct; 14(19):6586-92. PubMed ID: 16784862
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and SAR of conformationally restricted inhibitors of soluble epoxide hydrolase.
Jones PD; Tsai HJ; Do ZN; Morisseau C; Hammock BD
Bioorg Med Chem Lett; 2006 Oct; 16(19):5212-6. PubMed ID: 16870439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
